Owner Janssen Pharmaceutica N.V.

Inventors Khalil, Ehab M.; Winters, Michael Peter; Subasinghe, Nalin L.; Cummings, Maxwell David; Travins, Jeremy M.; Ballentine, Shelley; Gushue, Joan M.; Leonard, Kristi A.; Ali, Farah; Hufnagel, Heather

Agent Shelston IP

Pub. Number AU-A-2006227778

PCT Pub. Number WO2006/101860

Priority 60/662,518 16.03.05 US

Filing date 14 March 2006

Wipo publication date 28 September 2006

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group